This Edition
ARTICLE | Clinical News
Replagal agalsidase alfa enzyme replacement therapy regulatory update
WIR Staff
January 8, 2001 8:00 AM UTC
TKTX said the FDA requested additional data for its BLA for Replagal to treat Fabry disease. ...